New Jersey's Merck & Co to purchase Acceleron for $11.5bn in rare-disease-drug push - NewsBreak
#newjersey
#merck
#acceleron
3 years ago By Gomez — Merck & Co Inc., the Kenilworth, New Jersey-headquartered American multinational pharmaceutical company initially established in Germany by a Merck family
Merck to buy Acceleron for about $11.5 billion in rare disease drug push - NewsBreak
#merck
#acceleron
3 years ago By Tarikul — (Reuters) -Merck & Co said on Thursday it would buy Acceleron Pharma (NASDAQ:XLRN) Inc for about $11.5 billion, broadening its portfolio beyond aging cance
Merck spends $11.5B for Acceleron, possible blockbuster drug - NewsBreak
#merck
#acceleron
3 years ago By Vivian — Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and hear
Acceleron in advanced talks for $11B sale - NewsBreak
#acceleron
#biz
3 years ago By Faria — U.S. drugmaker Acceleron Pharma Inc is in advanced talks to be acquired by a large pharmaceutical company for more than $11 billion, Bloomberg News reporte
Acceleron in advanced talks for $11 billion sale - Bloomberg News - NewsBreak
#acceleron
#bloombergnews
3 years ago By Hernandez — (Reuters) - U.S. drugmaker Acceleron Pharma Inc is in advanced talks to be acquired by a large pharmaceutical company for more than $11 billion, Bloomberg